Reusing hypodermic syringes is the number one contributor to the spread of HIV/AIDS in the developing world. Millions of people are potentially affected each year. Fulcrum members invented and contributed to the development of syringe reuse prevention products. One of these devices, the BD SoloShot VX™, provides clinical flexibility by allowing variable dosing and drug reconstitution, then automatically locking after injection.
Reuse of single-use medical devices, including syringes and medication bags and vials, is gaining recognition as a developed world issue, too. Fulcrum principals are at the forefront of work to stop this growing problem. For more information on safe injection practices, visit the One and Only Campaign or the HonorReform Foundation.
BD™ and SoloShot® are trademarks of Becton, Dickinson, and Company.